These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 23867252)
1. Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors. Beebe K; Mollapour M; Scroggins B; Prodromou C; Xu W; Tokita M; Taldone T; Pullen L; Zierer BK; Lee MJ; Trepel J; Buchner J; Bolon D; Chiosis G; Neckers L Oncotarget; 2013 Jul; 4(7):1065-74. PubMed ID: 23867252 [TBL] [Abstract][Full Text] [Related]
2. Prospective identification of resistance mechanisms to HSP90 inhibition in KRAS mutant cancer cells. Rouhi A; Miller C; Grasedieck S; Reinhart S; Stolze B; Döhner H; Kuchenbauer F; Bullinger L; Fröhling S; Scholl C Oncotarget; 2017 Jan; 8(5):7678-7690. PubMed ID: 28032595 [TBL] [Abstract][Full Text] [Related]
3. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants. Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842 [TBL] [Abstract][Full Text] [Related]
4. Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects. Chan CT; Paulmurugan R; Gheysens OS; Kim J; Chiosis G; Gambhir SS Cancer Res; 2008 Jan; 68(1):216-26. PubMed ID: 18172314 [TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives. Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999 [TBL] [Abstract][Full Text] [Related]
6. Structure of the ATP-binding domain of Plasmodium falciparum Hsp90. Corbett KD; Berger JM Proteins; 2010 Oct; 78(13):2738-44. PubMed ID: 20635416 [TBL] [Abstract][Full Text] [Related]
7. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex. Stravopodis DJ; Margaritis LH; Voutsinas GE Curr Med Chem; 2007; 14(29):3122-38. PubMed ID: 18220746 [TBL] [Abstract][Full Text] [Related]
8. Spotlight on the microbes that produce heat shock protein 90-targeting antibiotics. Piper PW; Millson SH Open Biol; 2012 Dec; 2(12):120138. PubMed ID: 23271830 [TBL] [Abstract][Full Text] [Related]
9. The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1. Usmani SZ; Bona RD; Chiosis G; Li Z J Hematol Oncol; 2010 Oct; 3():40. PubMed ID: 20977755 [TBL] [Abstract][Full Text] [Related]
10. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives. Kim T; Keum G; Pae AN Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970 [TBL] [Abstract][Full Text] [Related]
11. Heat shock protein 90 regulates the stability of MEKK3 in HEK293 cells. Fang S; Fu J; Yuan X; Han C; Shi L; Xin Y; Luo L; Yin Z Cell Immunol; 2009; 259(1):49-55. PubMed ID: 19560753 [TBL] [Abstract][Full Text] [Related]
12. Systematic identification of the HSP90 candidate regulated proteome. Wu Z; Gholami AM; Kuster B Mol Cell Proteomics; 2012 Jun; 11(6):M111.016675. PubMed ID: 22337586 [TBL] [Abstract][Full Text] [Related]
13. First Structural View of a Peptide Interacting with the Nucleotide Binding Domain of Heat Shock Protein 90. Raman S; Singh M; Tatu U; Suguna K Sci Rep; 2015 Nov; 5():17015. PubMed ID: 26599366 [TBL] [Abstract][Full Text] [Related]
14. Redefining the Phenotype of Heat Shock Protein 90 (Hsp90) Inhibitors. Wang Y; Koay YC; McAlpine SR Chemistry; 2017 Feb; 23(9):2010-2013. PubMed ID: 27862436 [TBL] [Abstract][Full Text] [Related]
15. Structure-based and in silico design of Hsp90 inhibitors. Sgobba M; Rastelli G ChemMedChem; 2009 Sep; 4(9):1399-409. PubMed ID: 19685544 [TBL] [Abstract][Full Text] [Related]
16. Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2. Gallerne C; Prola A; Lemaire C Biochim Biophys Acta; 2013 Jun; 1833(6):1356-66. PubMed ID: 23485394 [TBL] [Abstract][Full Text] [Related]
17. Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors. Li Z; Jia L; Wang J; Wu X; Hao H; Wu Y; Xu H; Wang Z; Shi G; Lu C; Shen Y Eur J Med Chem; 2014 Nov; 87():346-63. PubMed ID: 25277067 [TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 90: inhibitors in clinical trials. Biamonte MA; Van de Water R; Arndt JW; Scannevin RH; Perret D; Lee WC J Med Chem; 2010 Jan; 53(1):3-17. PubMed ID: 20055425 [No Abstract] [Full Text] [Related]
19. Features of the Streptomyces hygroscopicus HtpG reveal how partial geldanamycin resistance can arise with mutation to the ATP binding pocket of a eukaryotic Hsp90. Millson SH; Chua CS; Roe SM; Polier S; Solovieva S; Pearl LH; Sim TS; Prodromou C; Piper PW FASEB J; 2011 Nov; 25(11):3828-37. PubMed ID: 21778327 [TBL] [Abstract][Full Text] [Related]
20. Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors. Zhang MQ; Gaisser S; Nur-E-Alam M; Sheehan LS; Vousden WA; Gaitatzis N; Peck G; Coates NJ; Moss SJ; Radzom M; Foster TA; Sheridan RM; Gregory MA; Roe SM; Prodromou C; Pearl L; Boyd SM; Wilkinson B; Martin CJ J Med Chem; 2008 Sep; 51(18):5494-7. PubMed ID: 18800759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]